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Acute pancreatitis (AP) is one common clinical acute abdominal disease, for which 
specific pharmacological or nutritional therapies remain elusive. Lactose, a macronutri-
ent and an inducer of host innate immune responses, possesses immune modulatory 
functions. The current study aimed to investigate potential modulatory effects of lactose 
and the interplay between the nutrient and pancreatic immunity during experimentally 
induced AP in mice. We found that either prophylactic or therapeutic treatment of lac-
tose time-dependently reduced the severity of AP, as evidenced by reduced pancreatic 
edema, serum amylase levels, and pancreatic myeloperoxidase activities, as well as by 
histological examination of pancreatic damage. Overall, lactose promoted a regulatory 
cytokine milieu in the pancreas and reduced infiltration of inflammatory neutrophils and 
macrophages. On acinar cells, lactose was able to suppress caerulein-induced inflam-
matory signaling pathways and to suppress chemoattractant tumor necrosis factor 
(TNF)-α and monocyte chemotactic protein-1 production. Additionally, lactose acted 
on pancreas-infiltrated macrophages, increasing interleukin-10 and decreasing tumor 
necrosis factor alpha production. Notably, lactose treatment reversed AP-associated 
infiltration of activated neutrophils. Last, the effect of lactose on neutrophil infiltration 
was mimicked by a galectin-3 antagonist, suggesting a potential endogenous target of 
lactose. Together, the current study demonstrates an immune regulatory effect of lactose 
to alleviate AP and suggests its potential as a convenient, value-added therapeutic mac-
ronutrient to control AP, and lower the risk of its systemic complications.
Keywords: lactose, inflammation, immunoregulation, neutrophils, macrophages
Abbreviations: AP, acute pancreatitis; CAMP, cathelicidin antimicrobial peptide; cDC, conventional dendritic cells; ERK, 
extracellular signal-regulated kinases; H&E, hematoxylin and eosin; IL-10, interleukin-10; KC, keratinocyte chemoattractant; 
LPS, lipopolysaccharides; MAP, mitogen-activated protein; MCP-1, monocyte chemotactic protein-1; MIP-2, macrophage 
inflammatory protein-2; MPO, myeloperoxidase; NF-κB, nuclear factor-kappaB; NKT, natural killer T cells; pDC, plasmacytoid 
dendritic cells; Treg, regulatory T cells; TGF-β, transforming growth factor-β; TNF-α, tumor necrosis factor alpha.
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inTrODUcTiOn
Acute pancreatitis (AP) is a common clinical abdominal disease 
with an increasing incidence worldwide and has become the 
leading cause of hospital admission for gastrointestinal disorders 
in many countries (1). AP begins with intra-acinar trypsinogen 
activation and autodigestion of the pancreas, which led to 
local inflammation (2). When the local inflammation becomes 
uncontrolled, it may lead to systemic inflammatory responses 
with impact on multiple organs including the lungs which are 
ultimately responsible for AP-associated mortality (3, 4). Despite 
extensive efforts to clarify its etiology and pathophysiological 
mechanisms, specific pharmacological and nutritional therapies 
of AP remain elusive. Therefore, strategic therapeutic or nutra-
ceutical interventions to limit local pancreatic inflammation, 
prevent, or treat diverse AP-associated complications are highly 
needed.
Both conventional views and recent studies have highlighted 
the importance of acinar cell inflammation, innate immune 
cells, and derived mediators in the pathophysiology of AP 
(5–7). Following acinar cell damage and release of inflammatory 
cytokines/chemokines, neutrophils, and macrophages, two del-
eterious immune cell types in the early stage of AP, infiltrate the 
pancreas, which are early hallmarks of the disease (8). Neutrophils, 
macrophages, as well as dendritic cells with distinct cell surface 
and intracellular markers have been associated with the devel-
opment and severity of acute inflammatory conditions (9–12). 
A balance between pro-inflammatory and anti-inflammatory 
mediators produced from acini and immune infiltrates is critical 
for the modulation of AP. Tumor necrosis factor (TNF)-α, mono-
cyte chemotactic protein (MCP)-1, and interleukin (IL)-10, 
known as cytokines/chemokines are important in the develop-
ment of AP (10, 13). Severity of pancreatitis is associated with 
increased pancreatic content of Ly6Chi monocytes/macrophages 
and is dependent upon the expression of TNF-α by these cells 
(10). MCP-1, a member of the C-C chemokine family, exerts 
strong chemoattractant activities in monocytes, macrophages, 
and lymphocytes. Treatment targeting MCP-1 has been shown to 
exert protective effects against AP (13, 14). Consequently, modu-
lation of immune cell activation and inflammatory cytokine/
chemokine production may be a rational approach to alleviate AP.
Lactose is a β-galactoside consisting of galactose and glucose 
residues, the main carbohydrate in mammalian breast milk. 
Lactose has demonstrated modulatory effects on regulatory 
T cells, THP-1 monocytes, and macrophages in vitro (15, 16) and 
its treatment has been evaluated in immunological conditions, 
including necrotic enteritis, Plasmodium berghei-induced pulmo-
nary infection, and sepsis with mixed implications (17–19). The 
anti- or pro- inflammatory effects of lactose seem to be related to 
its concentrations and primary molecular targets in the context of 
disease. Galectin-3 is a α-galactoside-binding lectin distributed 
in epithelial linings of many organs and in various inflammatory 
cells especially macrophages (20, 21). Galectin-3 chemoattracts 
monocytes/macrophages and marks macrophage activation 
(20, 21). The interaction of lactose with particular galectin mem-
bers largely determines the types of immune responses elicited 
during inflammation.
In this study, we aimed to address the question of whether 
lactose exerts modulatory effects on innate immune responses, in 
particular those mediated by innate immune cells and cytokines, 
as well as on acinar cell responses during experimental AP. In 




Female BALB/c mice of 6- to 8-week-old (Su Pu Si Biotechnology 
Co., Ltd., Suzhou, Jiangsu, China) were maintained in specific 
pathogen-free environment at the Animal Housing Unit of 
Jiangnan University (Wuxi, Jiangsu, China) under a controlled 
temperature (23–25°C) and a 12-h light/dark cycle. All animals 
were provided with standard laboratory chow and water ad libi-
tum. A period of 1 week was allowed for animals to acclimatize 
before any experimental operation was undertaken. All animal-
related experimental protocols were approved by the Institutional 
Animal Ethics Committee of Jiangnan University in compliance 
with the recommendations of national and international guide-
lines for the Care and Use of Laboratory Animals, and were 
performed in accordance with the guidelines therein. Five to 
eight animals were used in each group for the experiments and 
have been specifically indicated in the respective figure legends.
induction of aP
Mice were randomly assigned into control or experimental 
groups with eight animals in each group. Animals were given 3, 
6, and 10 hourly intraperitoneal (i.p.) injections of normal saline 
or saline containing caerulein (50 µg/kg, Sigma, St. Louis, MO, 
USA) as previously described (8). In our regimen, lactose (Sigma, 
St. Louis, MO, USA) at a dose of 100 mg/kg was given i.p. to mice 
either half an hour before or 1 h after the first caerulein injection 
as prophylactic or therapeutic experimental groups, respectively. 
1 h after the last injection, animals was sacrificed with a lethal 
dose of pentabarbitone sodium (20  mg/mL). Harvested blood 
was centrifuged (3,000 g, 10 min, 4°C), serum was collected, and 
stored at −80°C. Freshly harvested samples of pancreas were 
weighed, dried in oven (80°C, 48 h), and reweighed to determine 
pancreatic edema. Tissue samples including pancreas and lungs 
were stored at −80°C for subsequent experiments.
serum amylase Measurements
Serum was collected by allowing the blood to coagulate at ambi-
ent temperate for 25 min, and subsequently centrifuged at 3,000 g 
for 10 min at 4°C. The supernatant was then collected for analysis. 
An iodine-starch colorimetric method was used to measure 
serum amylase levels as previously described (22). Briefly, serum 
samples were incubated with a prewarmed substrate buffer 
(Jiancheng Bioengineering Institute, Nanjing, Jiangsu, China) for 
7.5 min at 37°C. Absorbance was measured, following addition of 
0.5 mL iodine and 3 mL ddH2O to the mixture, at 660 nm using 
a UV-2450 UV–VIS spectrophotometer (Shimadzu Corporation, 
Kyoto, Japan).
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Myeloperoxidase (MPO) activity
Myeloperoxidase activity was evaluated using an MPO assay kit 
(Jiancheng Bioengineering Institute, Nanjing, Jiangsu, China) 
according to the manufacturer’s protocol as previously described 
(22). Pancreatic tissues in 0.9% saline or homogenization medium 
provided by the MPO assay kit (1:19 mass/volume) were homog-
enized by a homogenizer (IKA, Staufen, Germany). Five percent 
of pancreatic tissue homogenates (200  µL) and chromogenic 
reagent (3 mL) were added to a sterile tube, and after mixing, it 
was put in water bath for 30 min at 37°C. Stop solution (provided 
by the assay kit) was added to the above mixtures to stop the 
reaction. Absorbance was then analyzed at 460 nm within 10 min 
and MPO activities are expressed as units/g tissue.
histology examination
Histological examination was performed as previously described 
(8). Ten hours after AP induction, freshly harvested pancreatic 
and lung tissues were fixed with 4% paraformaldehyde overnight. 
The tissues were then dehydrated with gradient ethanol solutions 
and embedded in paraffin blocks and cut into 5 µm sections. The 
sections were dewaxed in xylene, hydrated through upgraded 
ethanol solutions, and subsequently stained with hematoxylin 
and eosin (H&E). Pancreatic and lung injuries were examined 
under a DM2000 light microscope (Leica Microsystems GmbH, 
Wetzlar, Germany) at 200× magnification.
elisa
Tissue homogenates of mice receiving different treatments as 
well as isolated primary cells, including acinar cells, peripheral 
neutrophils, and peritoneal macrophages were assayed for inflam-
matory mediators using specific sandwich ELISA kits (Biolegend, 
San Diego, CA, USA). Previous procedures validated by our 
group were adopted, according to the manufacturer’s protocols. 
Absorbance was measured at 450  nm within 30  min, using an 
automated microplate reader (Multiskan™ GO; Thermo Fisher 
Scientific Oy, Vantaa, Finland). Concentrations of various inflam-
matory cytokines or chemokines were calculated based on the 
absorbance measurements, and are expressed as pg/mL.
Flow cytometry
Female BALB/c mice were treated with caerulein together with 
or without lactose and 3  h later cells from the pancreas were 
recovered. Single cell suspensions were stained for 30 min at 4°C 
after FccRII/III blocking in phosphate-buffered saline (PBS) con-
taining 2% fetal calf serum, 0.5% EDTA, and 0.1% sodium azide. 
Surface staining was performed with the following monoclonal 
antibodies (mAbs): anti-CD45 (eBioscience, clone 30-F11), 
-F4/80 (eBioscience, clone BM8), -CD11b (eBioscience, clone 
M1/70), -CD11c (eBioscience, clone N418), -IL-10 (eBioscience, 
clone JES5-16E3), -TNF-α (eBioscience, clone MP6-XT22), -Ly6G 
(eBioscience, clone 1A8), -CD62L (eBioscience, clone MEL-14), 
-TCRβ (eBioscience, clone H57-597), and -CD19 (eBioscience, 
clone 1D3). For determining macrophages and neutrophils, cells 
were surface stained with anti- F4/80, -CD11b, -Ly6G, -CD62L, 
and for B and T cells, cells were stained with anti-CD45, -CD11b, 
-TCRβ, and -CD19 followed by incubation for 30  min. For 
cytokine expression by macrophages, cells were stained with the 
following mAbs: anti-TNF-α, -IL-10. Stained cells were analyzed 
on a Becton Dickinson Fortessa flow cytometer.
isolation of Peripheral Blood 
neutrophils
Female BALB/c mice were treated with caerulein together with or 
without lactose, and 3 h later blood samples of mice were drawn 
using anticoagulant tubes and diluted with 2 mL PBS. Neutrophils 
were purified using density gradient centrifugation through 
Ficoll-Paque Plus. Contaminating erythrocytes were removed by 
red blood cell lysis buffer. Cells were resuspended in RPMI 1640 
medium and allowed to recover at 37°C in a humidified 5% CO2 
incubator and incubated with lipopolysaccharides (LPS, 1 µg/ml, 
Sigma-Aldrich, St. Louis, MO, USA) for 3 h before ELISA assays.
isolation of Primary Peritoneal 
Macrophages
Primary peritoneal macrophages were isolated as previously 
described (23) with modifications. Female BALB/c mice were 
treated with caerulein together with or without lactose and 3 h 
later mice were anesthetized with 10 mg/mL of pentabarbitone 
sodium and closed peritoneal lavage was performed using 10 mL 
ice-cold PBS. Peritoneal exudate cells were collected, washed with 
PBS, and resuspended in supplemented Dulbecco’s Modified 
Eagle Medium (DMEM). Peritoneal macrophages were allowed 
to adhere in 6-well plates at 37°C in a humidified 5% CO2 incuba-
tor, incubated with LPS (1 µg/ml) for 3 h, and then subjected to 
subsequent ELISA assays.
Primary acinar cell Preparation
Pancreatic acinar cells were freshly prepared from mouse 
pancreas by collagenase treatment (24). In brief, pancreas from 
three mice were removed, infused with digestive buffer (140 mM 
NaCl, 4.7  mM KCl, 1.13  mM MgCl2, 1  mM CaCl2, 10  mM 
glucose, 10  mM HEPES, pH 7.2) containing 200  IU/mL colla-
genase (Worthington Biochemical Corp., Lakewood, NJ, USA) 
together with 0.5 mg/mL soybean trypsin inhibitor (Worthington 
Biochemical Corp.), and then incubated in a shaking water bath 
for 30 min at 37°C. The digested tissue was centrifuged through 
50 mg/mL bovine serum albumin and washed twice with diges-
tive buffer. Single cells or 5–8 cell clusters were resuspended 
in DMEM/F12 medium, counted using a hemocytometer and 
equally divided into groups as confirmed by protein estimations. 
Cells were allowed to recover at 37°C in a humidified 5% CO2 
incubator, and cell viability was confirmed by trypan blue exami-
nation to be more than 95% before treatment. For treatment, cells 
were incubated with caerulein (10−7 M) together with or without 
lactose (0.5 mM) for 3 h before subsequent assays.
Western Blot analysis
Signaling proteins from acinar cell lysates were analyzed by 
Western blot analysis as previously described (25). Anti-
bodies against phosphor-extracellular signal-regulated kinases 
(ERK)1/2 (#4370), total ERK (#4695), phosphor-p38 (#9211), 
total p38 (#9212), and p65 subunit of nuclear factor-κB (NF-κB) 
FigUre 1 | Prophylactic or therapeutic lactose treatment mitigates the severity of experimental acute pancreatitis in a time-related manner. Pancreatic edema  
(a) and serum amylase (B), pancreatic myeloperoxidase activity (c), and pancreatic histology (D) were determined. Vehicle (Veh): saline treatment. Caerulein (Cae): 
caerulein hyperstimulation treatment. Prophylactic: lactose administered 30 min before starting caerulein treatment. Therapeutic (The): lactose administered 1 h after 
starting caerulein treatment. Data are mean ± SEM from at least three independent experiments of six to eight independent mice in each group. *p < 0.05, 
**p < 0.01, ***p < 0.001, ****p < 0.0001 vs. corresponding Veh by two-way analysis of variance (ANOVA); #p < 0.05, ##p < 0.01, ###p < 0.001 vs. corresponding Cae 
by two-way ANOVA.
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(#3033) were purchased from Cell Signaling Technology (Beverly, 
CA, USA).
statistical analysis
Data are expressed as mean ± SEM. The parametric distribution 
of the results was confirmed using Kolmogorov–Smirnov test. 
Statistical analysis was performed by one-way or two-way (two 
independent variables) analysis of variance (ANOVA) followed by 
Tukey’s post hoc test using GraphPad Prism (version 5; GraphPad 
Software Inc., San Diego, CA, USA). P < 0.05 was considered to 
indicate a statistically significant difference.
resUlTs
lactose Treatment alleviates the severity 
of caerulein-induced aP
Prophylactic or therapeutic administration of lactose (100 mg/kg) 
was evaluated in the most widely used mouse model of caerulein 
(50  µg/kg) hyperstimulation-induced AP. Mild, moderate, and 
severe AP were induced by 3, 6, and 10 hourly caerulein injec-
tions, respectively (8). Lactose treatment significantly reduced 
AP symptoms, including pancreatic edema, hyperamylasemia, 
and increased pancreatic MPO activities in a time-related man-
ner. Either prophylactic or therapeutic lactose administration 
attenuated caerulein-induced pancreatic edema, increases in 
serum amylase and in pancreatic MPO levels (Figures  1A–C). 
Histological examination of pancreatic sections from mice with 
severe AP confirmed the protective effects by lactose treatment in 
AP against acinar cell injury, edema, and immune cell infiltration 
in the pancreas (Figure 1D). In addition, lactose administration 
protected AP-associated lung injury as evidenced by reduced lung 
MPO activities as compared to the caerulein group. Histological 
examination revealed decreased alveolar thickening and immune 
cell infiltration in the lungs of lactose-treated mice as compared 
to the AP group (Figures S1A,B in Supplementary Material). 
These findings suggest that lactose attenuates the severity of 
caerulein-induced AP and associated lung injury.
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lactose Modulates early immune cell 
infiltration into the Pancreas and Pancreatic 
cytokine/chemokine Production
Dysregulated innate immune cell infiltration and a consequent 
imbalance between pro-inflammatory and anti-inflammatory 
cytokine/chemokine production are early hallmark pathological 
events of AP. To evaluate the effects of lactose on innate immune 
cell responses during early development of AP, BALB/c mice were 
treated with caerulein (50 µg/kg) together with or without lactose. 
After 3  h, the frequencies (gated on CD45+ cells) and absolute 
numbers of macrophages (CD11b+F4/80+), conventional dendritic 
cells (cDCs, F4/80−CD11b+CD11c+), and plasmacytoid DCs 
(pDCs, F4/80−CD11c+CD11bmed) that infiltrated into the pancreas 
were analyzed. We found that the total number of macrophages was 
decreased in mice induced with AP, while the two subpopulations 
of DCs were not significantly altered as compared to untreated 
control mice (Figure 2A). Therefore, lactose treatment did not alter 
the total number of macrophages, pDCs, or cDCs (Figure 2A).
Inflammatory cytokines play an important role in the aggrava-
tion of AP and development of systemic inflammatory responses. 
We analyzed the modulatory effects of lactose on pancreatic cytokine 
production after 10 h induction of AP. Prophylactic or therapeutic 
treatment with lactose (100 mg/kg) resulted in decreased pancre-
atic MCP-1 production as compared to mice with severe AP, with 
more pronounced effects observed with prophylactic treatment 
(Figures  2B–D). In addition, lactose modulated the production 
of TNF-α and to a lesser extent macrophage inflammatory pro-
tein-2 production. In contrast, lactose did not alter AP-associated 
production of transforming growth factor-β (TGF-β), keratinocyte 
chemoattractant, or IL-10 (Figures  2E–G). Together, these data 
suggest that lactose treatment modulates the production of pro-
inflammatory cytokines/chemokines in the pancreas.
lactose Modulates neutrophil infiltration 
and activation During early aP and 
cytokine/chemokine Production From 
Peripheral neutrophils
Further analysis of the infiltrated neutrophils (CD11b+Ly6G+) 
revealed that a large number of CD11b+Ly6G+ neutrophils were 
recruited to the pancreas 3 h after AP induction. Treatment with 
lactose resulted in attenuated infiltrating neutrophils (Figure 3A) 
and a higher CD62L+ proportion of infiltrated neutrophils 
(Figure  3B). We analyzed peripheral neutrophils in parallel 
and found that the levels of TNF-α production by peripheral 
neutrophils were significantly reduced in lactose-treated group as 
compared to the AP group (Figures 3C,D). Together, our results 
demonstrate that lactose modulates early neutrophil infiltration 
and activation in the pancreas, as well as functional cytokine 
production by peripheral neutrophils during AP.
lactose Modulates Macrophage 
infiltration, Phenotype conversion, and 
cytokine Production During early aP
In addition to neutrophils, macrophages represent another major 
source of inflammatory mediators in AP. Hence, we examined the 
infiltration and phenotypes of macrophages together with analy-
ses of associated cytokine/chemokine production. AP induction 
was accompanied by an increase of TNF-α+ macrophages in the 
pancreas. Treatment with lactose resulted in increased IL-10+ 
macrophages and decreased TNF-α+ macrophages in the pan-
creas as compared to caerulein-induced AP mice (Figure 4A). 
In parallel, primary peritoneal macrophages were isolated and 
we found that lactose suppressed LPS induced elevation of 
TNF-α and MCP-1 in peritoneal macrophages (Figures 4B,C). 
These findings indicate that lactose exhibits regulatory effects on 
pancreatic macrophages, causing reduced pancreatic infiltration 
of these cells and inducing a phenotypic switch from an inflam-
matory toward a regulatory state.
In addition to innate immune cells, the effects of lactose 
on lymphocyte infiltration were also examined. Pancreatic B 
and T cells were not significantly changed upon AP induction, 
although a trend of decrease (p = 0.055) was observed for T cells. 
Lactose treatment did not affect T cell count but mildly reduced 
B cells (p = 0.039) (Figure S2 in Supplementary Material).
lactose attenuates caerulein-induced 
McP-1 Production and activates 
erK1/2-p65 signaling Pathway in 
Pancreatic acinar cells
Damaged pancreatic acinar cells produce inflammatory media-
tors that mediate local inflammation. Earlier studies have sug-
gested that mitogen-activated protein (MAP) kinase and NF-κB 
signaling pathway participate in the pathophysiology of AP to 
induce the expression and release of inflammatory cytokines and 
chemokines (24). Using primary acinar preparations, we observed 
inhibitory effects of lactose (0.5  mM) on caerulein (10−7  M) 
induced MCP-1 production, but not TNF-α (Figures  5A,B). 
Furthermore, ERK1/2 was phosphorylated and activation in 
isolated acinar cells stimulated with caerulein, and lactose treat-
ment downregulated p-ERK1/2 expression (Figures  5C,D). In 
contrast, either treatment with caerulein alone or with lactose 
did not alter p38 activation (Figures 5C,E). Further examination 
on the transcription factor NF-κB showed that lactose reversed 
caerulein-induced nuclear translocation and activation of NF-κB 
p65 subunit (Figures  5C,F). These results indicate that lactose 
suppresses ERK1/2 and NF-κB p65 signaling, leading to inhibi-
tion of cytokine production in pancreatic acinar cells.
galectin-3 antagonism Mimicking lactose 
Modulates neutrophil recruitment and 
activation in the Pancreas after aP 
induction
Last, we examined potential molecular targets of lactose for its 
immunomodulatory effects during AP. Earlier, lactose has been 
found to inhibit galectin-3 binding and galectin-3 is known to 
promote activation of inflammatory macrophages and neu-
trophil migration (26–28). BALB/c female mice were treated 
with caerulein (50 µg/kg) alone or together with the galectin-3 
inhibitor N-acetyl-d-lactosamine. Neutrophil infiltration and 
activation as well as the neutrophil-derived enzyme MPO 
FigUre 2 | Lactose promotes early immune cell infiltration and a modulatory cytokine production profile in the pancreas. Female BALB/c mice were treated with 
caerulein together with or without lactose and 3 h later cells were recovered from the pancreas. (a) Frequency (gated on CD45+ cells) and absolute number of 
macrophages (CD11b+ F4/80+), conventional dendritic cells (F4/80− CD11b+ CD11c+) and plasmacytoid dendritic cells (F4/80− CD11b+ CD11cmed) per pancreas 
were shown. Data are representative or median values ± interquartile range from four independent experiments with a minimum of five independent mice. (B–g) The 
levels of pancreatic tumor necrosis factor alpha, monocyte chemotactic protein-1, macrophage inflammatory protein-2, keratinocyte chemoattractant, transforming 
growth factor-β, and IL-10 production were shown. Data are mean ± SEM from at least three independent experiments of at least six independent mice in each 
group. *p < 0.05, **p < 0.01, ***p < 0.001 by one-way analysis of variance.
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activity were subsequently examined. Our results demonstrate 
that N-acetyl-d-lactosamine mimicking the effects of lactose, sig-
nificantly decreased the frequency of CD11b+Ly6G+ neutrophils 
(Figure  6A). Accordingly, we found that MPO activity was 
reduced in N-acetyl-d-lactosamine-treated group as compared 
to caerulein only treated group (Figure  6B). Together, these 
FigUre 3 | Lactose modulates neutrophil infiltration and activation during early acute pancreatitis and cytokine/chemokine production from peripheral neutrophils. 
Female BALB/c mice were treated with caerulein together with or without lactose and 3 h later cells were recovered from the pancreas. Cells were directly stained 
for the expression of CD45, Ly6G, CD11b, and CD62L. (a) The frequency and absolute number of neutrophils per pancreas were shown. (B) The frequency of 
CD62L+ neutrophils in the pancreas was shown. Results are representative or median values ± interquartile range from two independent experiments with a 
minimum of five independent mice. (c,D) Peripheral neutrophils were isolated, and incubated with lipopolysaccharides (1 µg/ml) for 3 h and the levels of tumor 
necrosis factor alpha (c) and monocyte chemotactic protein-1 (D) were analyzed by ELISA. Data are mean ± SEM from at least three independent experiments of 
at least five independent mice in each group. *p < 0.05, **p < 0.01 by one-way analysis of variance.
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data suggest that galectin-3 may be the potential downstream 
molecular target of lactose.
DiscUssiOn
The current study demonstrates that lactose exerts immu-
nomodulatory effects to alleviate experimental AP. The proposed 
mechanisms of action are: lactose reverses AP-induced infiltra-
tion of activated neutrophils and increases regulatory (IL-10-
producing) vs. inflammatory (TNF-α-producing) macrophage 
ratio. Lactose directly attenuates caerulein-induced inflamma-
tory signaling pathway and MCP-1 production in acinar cells. 
This study provides evidence that lactose treatment limits local 
inflammation and prevents exacerbated inflammatory responses 
during AP (Figure 7).
Lactose has been documented to possess immune modulatory 
effects. Lactose, isolated from human breast milk, has been found 
to induce the cathelicidin antimicrobial peptide (CAMP) gene 
encoding the only human CAMP LL-37 in THP-1 monocytes, 
macrophages, as well as in the colonic epithelial cells HT-29 
and T84 (16), suggesting its importance in neonatal innate 
immunity and intestinal homeostasis. Alpha (α)-lactose-treated 
mice exhibited enhanced acute and memory responses against 
mucosal pathogens (29), indicating lactose treatment as a con-
venient and inexpensive approach in mucosal immunopathology. 
In addition, milk oligosaccharide derivative sialyl(α 2,3) lactose 
FigUre 4 | Lactose modulates macrophage infiltration, phenotypes and cytokine production during early acute pancreatitis. Female BALB/c mice were treated with 
caerulein together with or without lactose and 3 h later cells were recovered from the pancreas. (a) Pancreatic cells were stimulated 4 h with LPS (1 µg/ml) in the 
presence of brefeldin A and then stained for IL-10 and tumor necrosis factor alpha (TNF-α). Data are representative or median values ± interquartile range from two 
independent experiments with a minimum of five independent mice. (B,c) Peritoneal macrophages were isolated from peritoneal exudate cells followed by a 
recovery period and then stimulated with lipopolysaccharides (1 µg/ml) for 3 h and the levels of TNF-α (B) and monocyte chemotactic protein-1 (c) production were 
determined. Results are mean ± SEM from at least three independent experiments of at least five independent mice in each group. *p < 0.05, **p < 0.01, 
***p < 0.001 by one-way analysis of variance.
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has been shown to promote intestinal inflammation through 
interaction with toll-like receptor 4 in a mouse model of colitis 
(30). In this study, supplementation with 25 mM lactose did not 
result in inflammation in mice. Oligosaccharides may, therefore, 
play a role in the regulation of mucosal immunity. In line with 
these, lactose has been suggested as a potential alternative to 
growth-promoting antibiotic in controlling necrotic enteritis 
(19). Recently, α-lactose has been shown to improve the survival 
of mice with sepsis by tim-3 blockade to prevent natural killer 
T (NKT) cell apoptosis (17), supporting its role in NKT  cell 
modulation and systemic immunity. On the other hand, lactose 
has been found to inhibit human CD4+CD25+CD127− regula-
tory T (Treg)-mediated suppression of Th1 and Th17 immune 
responses in vitro (15). These results may be associated with the 
fact that oligosaccharides reach lamina propria and that lactose 
can induce harmful inflammatory responses by disrupting 
Treg-mediated regulation in individuals susceptible to chronic 
inflammatory diseases. Another recent study has demonstrated 
that 300  mM of α-lactose injected into mice infected with 
Plasmodium berghei exacerbate pulmonary immunopathology 
by blocking the interaction of galectin-9 and its receptor (18). 
It can be postulated that the anti- or pro-inflammatory effects of 
lactose may be related to its concentrations and primary molecu-
lar targets in the disease context. For example, pro-inflammatory 
effects of lactose have been suggested via galectin-9 antagonism 
to abrogate downstream tim-3-mediated immune regulation 
(15, 31). In this study, we found that lactose and the galectin-3 
inhibitor N-acetyl-d-lactosamine significantly reduced neutro-
phils infiltration during caerulein induced development of AP, 
suggesting that lactose may act via antagonizing galectin-3. The 
concentration of lactose (100 mg/kg) was selected from earlier 
in vivo studies to be relevant to its nutritional values (30, 32, 33), 
and also determined by preliminary experiments as the lowest 
effective concentration. The route of administration, i.p., ensures 
that the observed effects are those of lactose and not its metabolites 
or digested products (e.g., by avoiding metabolism by the liver) 
and is relevant to the parenteral route in clinical nutrition (34). 
Our data are in line with previous studies supporting that lactose 
may bind to and antagonize galectin-3 (35). Galectin-3 has been 
shown to mediate neutrophil migration (27) and to interact with 
naive and primed neutrophils, promoting neutrophil-mediated 
innate immune responses (36). Furthermore, galectin-3 also 
attracts monocytes and macrophages (20), and induces produc-
tion of inflammatory mediators in various conditions (21, 28, 
37, 38). Ours together with earlier studies provide evidence that 
milk oligosaccharides acting via its intracellular molecular target 
play an important role in the regulation of mucosal immunity in 
the pancreas.
Conventional views and recent studies have highlighted innate 
immunity and acinar cell inflammation in the pathogenesis of AP (7). 
FigUre 5 | Lactose attenuates caerulein-induced cytokine/chemokine production and p-extracellular signal-regulated kinases(ERK)1/2-NF-κB p65 signaling 
pathway activation in pancreatic acinar cells. Acinar cells were isolated from fresh pancreas and treated with caerulein (10−7 M) together with or without 0.5 mM 
lactose. Shown are the levels of tumor necrosis factor alpha (a) and monocyte chemotactic protein-1 (B) production by ELISA and Western blot analysis (c) of 
p-ERK1/2, ERK1/2, p-p38, p38, nuclear (n), and cytosolic (c) p-NF-κB p65 and densitometry analysis (D–F). Results are mean ± SEM from at least three 
independent experiments of at least three independent mice in each group. *p < 0.05, **p < 0.01 ***p < 0.001 by one-way analysis of variance.
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FigUre 6 | An antagonist of galectin-3 mimicking lactose suppresses neutrophil recruitment and activation in the pancreas after AP induction. Female BALB/c mice 
were treated with caerulein together with or without N-acetyl-d-lactosamine and 3 h later cells were recovered from the pancreas. (a) The frequency of CD62L+ 
neutrophils in the pancreas was shown. Results are representative or median values ± interquartile range from three independent experiments with a minimum of 
five to six independent mice. (B) Pancreatic myeloperoxidase activities were shown. Results are mean ± SEM from two independent experiments of at least five 
independent mice in each group. *p < 0.01, **p < 0.01, ***p < 0.001, ****p < 0.0001 by one-way analysis of variance.
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Immune cells and derived inflammatory mediators, importantly 
cytokines/chemokines determine the disease severity (6). We 
observed that caerulein hyperstimulation caused activation 
and infiltration of neutrophils and inflammatory macrophages, 
which may be reversed by lactose treatment. AP induction 
was associated with an increase in CD11b+Ly6G+ neutrophils 
and a decrease in the frequency (gated on CD11b+Ly6G+) of 
CD62L+ neutrophils. CD62L is an adhesion molecule present on 
granulocytes, monocytes, and lymphocytes and its regulation is 
closely related with the disease states (9, 39). We have found that 
caerulein-induced AP is associated with CD62L shedding from 
the cell surface of activated neutrophils and lactose treatment 
restored its expression. In view of the role of CD62L in leukocyte 
rolling along endothelial cells during migration, its upregula-
tion by lactose may be to protect against neutrophil trafficking, 
neutrophil-mediated pro-inflammatory responses, and manifes-
tation of systemic inflammatory responses. Similar observations 
have been reported in acute respiratory distress syndrome, where 
FigUre 7 | Lactose promotes modulatory immune responses during caerulein-induced experimental acute pancreatitis (AP) by antagonizing galectin-3. In our 
study, lactose protects mice against AP induced by caerulein via regulating the infiltration of neutrophils and macrophages, reducing the release of inflammatory 
mediators especially the cytokine tumor necrosis factor alpha and the chemokine monocyte chemotactic protein-1, inhibiting ERK1/2–p65 activation. In addition, 
lactose treatment promotes IL-10-producing macrophages in the pancreas and may bind galectin-3 to alleviate the severity of AP.
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blood and alveolar neutrophils of patients exhibited increased 
CD11b and reduced CD62L expression compared to healthy cir-
culating cells (9). Reversion of this phenotypic change by lactose 
indicates that its modulatory effect is associated with decreased 
infiltration of activated neutrophils. Furthermore, we have found 
that caerulein induction of AP results in increased frequency of 
TNF-α-producing macrophages, and lactose treatment caused 
decreased frequency of TNF-α+ macrophages and increased 
frequency of IL-10+ macrophages. Increased pancreatic Ly6Chi 
monocytes/macrophages are shown to be positively related to the 
severity of AP, which is dependent upon the expression of TNF-α 
by these cells (10). Interfering with M2 polarization has been 
reported to enhance the inflammatory status of macrophages 
during pancreatitis (11), and IL-10 production has been shown 
to impair neutrophil recruitment in inflammatory and infectious 
conditions (40, 41). Along with reduced infiltration of activated 
neutrophils and macrophages in lactose-treated mice, MCP-1 and 
TNF-α levels were found to be suppressed in pancreatic tissues, in 
addition to peripheral neutrophils and peritoneal macrophages. 
Selected cytokine/chemokine modulation by lactose may result 
from an overall effect on differential regulation of their cellular 
sources in the pancreas. The resultant reduction of cytokine 
and chemokine production prevents augmented inflammatory 
responses from a positive inflammatory feedback circuit (42).
Acinar cell inflammation with activation of MAP kinases and 
the transcription factor NF-κB is a key pathological event in early 
AP (2, 24, 25, 43). Supraphysiological concentrations of caerulein 
induces ERK1/2 phosphorylation and activation in pancreatic 
acini (44). NF-κB transactivation aggravates acute pancreatic 
inflammatory responses and MAP kinases regulate the activation 
of NF-κB by mediating phosphorylation of its inhibitory-κB (IκB) 
protein, to allow NF-κB translocation into the nucleus followed by 
inflammatory gene expression (44–46). Here, we found that MAP 
kinases ERK1/2, but not p38 activation was inhibited by lactose in 
acinar cells, concomitant with an attenuated NF-κB p65 nuclear 
translocation and activation. It can be speculated that different 
upstream MAP kinases are regulated by lactose. Consequently, 
caerulein-induced production of TNF-α and MCP-1 was reduced 
by lactose, which is in agreement with previous studies, showing 
that inhibition of MAP kinase signaling in acinar cells leads to 
downregulation of chemokines including MCP-1 (24). Our data 
fully imply that lactose regulates the development of AP, which 
is dependent on the activation of ERK1/2-NF-κB p65 signaling 
pathway and the release of inflammatory mediators.
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In summary, our results show that lactose has positive effects 
on innate immune cell and acinar cell responses against caerulein-
induced AP, revealing the interplay between this nutrient with 
pancreatic immunity and suggests the potential molecular target 
during this condition. As a curative treatment for AP remains 
obscure, the current study provides basic experimental evidence 
to develop nutritional intervention strategies to improve clinical 
management of AP. The milk oligosaccharide lactose with anti-
inflammatory properties during AP may be considered as a con-
venient, safe (for tolerant individuals), and value-added nutrient 
to control local inflammation and lower the risk of AP-associated 
systemic complications.
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FigUre s1 | Lactose treatment modulates the severity of experimental 
AP-associated lung injury. Lung myeloperoxidase activity (a) and histology  
(B) were determined. Vehicle: saline treatment. Caerulein: caerulein 
hyperstimulation treatment. Prophylactic: lactose administered 30 min before 
starting caerulein treatment. Therapeutic: lactose administered 1 h after starting 
caerulein treatment. Data are mean ± SEM from at least three independent 
experiments of six to eight independent mice in each group. **p < 0.01, 
***p < 0.001 vs. vehicle by two-way analysis of variance.
FigUre s2 | Effects of lactose on pancreatic B and T cells following acute 
pancreatitis induction. Female BALB/c mice were treated with caerulein together 
with or without lactose and 3 h later cells were recovered from the pancreas. 
Cells were directly stained for the expression of CD45, Ly6G, CD11b, CD19, and 
TCRβ. B and T cell numbers per pancreas were shown. Results are 
representative or median values ± interquartile range from two independent 
experiments with a minimum of five independent mice.
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